Insulet stockPODD
Insulet trades at $156.12, 56.0% below its 52-week high (Nov 20, 2025). The price is above its 50-day but below its 200-day average: a bounce within a downtrend. −45.1% year to date, −50.3% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 25, 2027.
- BenzingaWells Fargo Maintains Equal-Weight on Insulet, Raises Price Target to $172
- BenzingaBernstein Maintains Outperform on Insulet, Raises Price Target to $200
- BenzingaRBC Capital Maintains Outperform on Insulet, Raises Price Target to $180
Ratings, candles, signals and the screener for PODD — after you log in
Open the terminalFrequently asked questions about Insulet
What is the Insulet stock price?
At the close on Nov 5, 2026: $156.12 (−5.39% on the day). 52-week high: $354.88 on Nov 20, 2025. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Insulet report earnings?
The next quarterly report is on Feb 25, 2027. Last quarter, earnings per share changed +60% year over year, revenue +19%.
Does Insulet pay dividends?
No, Insulet does not pay dividends.
Where does Insulet trade and how to buy it?
Ticker PODD, exchange Nasdaq, listed since 2007. You can buy it through a broker with access to US exchanges.
Should I buy Insulet now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for PODD are in the terminal after you log in.